Alaa Elkordy

Alaa Elkordy

Auto-generated profile, based on publicly available information

Alaa Elkordy

Tanta University

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2019 in Journal of Clinical Neuroscience
Verified
Journal Article
Closed access
HFHeba Faheem
Heba Faheem
AMAhmed Mansour
Ahmed Mansour
AEAlaa Elkordy
Alaa Elkordy
SRSherif Rashad
Sherif Rashad
MSMohamed Shebl
Mohamed Shebl
TTTeiji Tominaga
Teiji Tominaga

1 March 2025 in Physiological Genomics
Verified
Journal Article
Closed access
HFHeba Faheem
Heba Faheem
RARana Alawadhi
Rana Alawadhi
EBEman H. Basha
Eman H. Basha
RIRadwa Ismail
Radwa Ismail
HIHoda A. Ibrahim
Hoda A. Ibrahim
YEYasmeen M. El-Harty
Yasmeen M. El-Harty
Celastrol inhibits the production of proinflammatory cytokines in the testicular tissue by specifically targeting the TLR4/MyD88/NF- κB signaling cascade pathways. This indicates that celastrol may serve as a promising new therapeutic target for treating diabetic reproductive dysfunction.

31 July 2024 in Nutritional Neuroscience
Verified
Journal Article
Closed access
RIRadwa Ismail
Radwa Ismail
Walaa A. NegmWalaa A. Negm
Walaa A. Negm
EBEman H. Basha
Eman H. Basha
FRFatma H. Rizk
Fatma H. Rizk
NANashwah G. M. Attallah
Nashwah G. M. Attallah
AAAsmaa Ramadan Azzam
Asmaa Ramadan Azzam
Introduction: Autism spectrum disorders (ASDs) are a group of neurodevelopmental disorders with poor social interaction, communication issues, aberrant motor movements, and limited repetitive interests and behaviour. Spirulina platensis (SP) contains several multi-nutrients and has a wide range of neuroprotective properties.Aim: The target of the current experiment is to detect the protective effects of S. platensis on valproic-induced autism in adult female albino rats' siblings for the first time.Materials and Methods: Twelve Pregnant rats were separated into four main groups; Group I (control); Group II (S. platensis); Group III (autistic group); and Group IV (autistic SP-treated group). Fifteen offspring pups from each group were sacrificed, brain was divided for biochemical analysis as superoxide dismutase and malondialdehyde were evaluated spectrophotometrically while interleukin-6, interleukin-12, Bcl-2-associated X protein, B-cell lymphoma-2, Beclin-1, brain-derived neurotrophic factor were assessed by ELISA, other division of brain were used for gene expression of PI3k, Akt and mTOR pathway, last division of brain were stained using (H&E) and Giemsa stains. Tumour necrosis factor alpha (TNF-α) and Synaptophysin (SYN) markers were used for immunohistochemical staining.Results: Autistic Group (III) showed an increment in levels of MDA, IL-6, IL12 and BAX while showing a decrement in SOD, Bcl-2 and Beclin-1 as well as increased PI3k, Akt and mTOR gene expression. Autistic Group (III) also exhibited hypocellularity and disorganization of hippocampal and prefrontal cortex cells. The autistic SP-treated group (IV) showed improvement in these biochemical markers and pathological changes. Our findings suggest that Spirulina platensis will be significant in managing autism.

27 August 2025 in Comprehensive Physiology
Verified
Journal Article
Closed access
HFHeba Faheem
Heba Faheem
RARana Alawadhi
Rana Alawadhi
EBEman H. Basha
Eman H. Basha
RERasha A. Abd Ellatif
Rasha A. Abd Ellatif
MAMona A. Abdel‐Kareem
Mona A. Abdel‐Kareem
FRFatma H. Rizk
Fatma H. Rizk

1 July 2025 in World Neurosurgery
Verified
Journal Article
Open access
HAHazem Abdelkhalek
Hazem Abdelkhalek
IMIslam El Malky
Islam El Malky
AEAlaa Elkordy
Alaa Elkordy
RARaed Ahmed
Raed Ahmed
EAEssam Abdelhameed
Essam Abdelhameed
AEAhmed Elhfnawy
Ahmed Elhfnawy
Most patients with idiopathic intracranial hypertension (IIH) have venous sinus stenosis. In the previous decade, venous sinus stenting has emerged as an ultimate treatment for resistant or refractory cases with IIH. However, studies in this regard are relatively few, especially from lower income countries. We aimed to evaluate the feasibility and efficacy of venous sinus stenting in our tertiary center. We retrospectively reviewed our prospectively collected database from January 2021 to January 2023 and recruited eligible patients with IIH and venous sinus stenosis who underwent stenting. We recruited 113 patients, all of them were females with a mean age of 30 ± 8 years and mean BMI of 30 ± 3.1. Stenting was technically successful in all our patients. Post stenting angioplasty was warranted in three cases (2.6%). Complications occurred in one case (0.9%) in the form of a rim of subdural hematoma without any clinical sequelae. At 3 months follow-up, 93 patients (82.3%) experienced complete relief of their symptoms, whereas 11 patients (9.7%) still had headache without papilledema and 9 patients (8%) had papilledema. Seven patients (6.2%) received ventriculoperitoneal shunting and two patients (1.8%) experienced restenosis and received another stenting procedure. Stenting of the venous sinus stenosis in IIH patients is effective and safe treatment and can be accomplished with a very low complication rate and relatively higher success rate.

2 March 2025 in Journal of Biochemical and Molecular Toxicology
Verified
Journal Article
Closed access
MSMonira A. Seleem
Monira A. Seleem
OSOla M. Salem
Ola M. Salem
EBEman Basha
Eman Basha
HIHoda A. Ibrahim
Hoda A. Ibrahim
AEAmira Mostafa Elshamy
Amira Mostafa Elshamy
HFHeba Faheem
Heba Faheem